Angiotensin 1/2 (5-7): Vasoconstrictor Peptide for Blood Pressure and Pathogenesis Research

Executive Summary: Angiotensin 1/2 (5-7), with the sequence H2N-Ile-His-Pro-OH and molecular formula C₁₇H₂₇N₅O₄, is a validated vasoconstrictor peptide derived from angiotensinogen via the renin-angiotensin system (RAS) (Oliveira et al., 2025). It exerts physiological effects by increasing blood pressure through smooth muscle contraction and dipsogenic activity. The peptide is highly soluble in DMSO (≥36.5 mg/mL), ethanol (≥50 mg/mL), and water (≥50 mg/mL), supporting diverse experimental designs (APExBIO). Mass spectrometry and HPLC confirm its 98.36% purity and molecular weight (365.43 Da). Recent evidence suggests that N-terminally truncated angiotensin peptides, including Angiotensin 1/2 (5-7), potentiate SARS-CoV-2 spike protein binding to cellular receptors, highlighting its emerging relevance in viral pathogenesis studies (Oliveira et al., 2025).

Biological Rationale

Angiotensin 1/2 (5-7) is a biologically active tripeptide fragment derived from enzymatic cleavage of angiotensinogen, a liver-produced serum globulin (Oliveira et al., 2025). The renin-angiotensin system tightly regulates cardiovascular homeostasis, blood pressure, and fluid balance. Angiotensin I (1–10), an inactive decapeptide, is processed to shorter, active forms including Angiotensin II (1–8) and further truncated products such as Angiotensin (5-7). These truncated peptides retain or even enhance specific biological activities, such as vasoconstriction and stimulation of thirst (dipsogenesis). Angiotensin 1/2 (5-7) specifically acts through potent vasoconstrictor mechanisms, making it a critical tool for dissecting RAS-mediated events in vascular physiology and pathophysiology. The peptide’s formation and activity are conserved across mammalian species, facilitating translational research in both human and animal models (Angiotensin 1/2 (5-7): A Vasoconstrictor Peptide Powerhou...).

Mechanism of Action of Angiotensin 1/2 (5-7)

Angiotensin 1/2 (5-7) exerts its biological effects primarily as a vasoconstrictor peptide hormone (APExBIO). Upon formation, it interacts with vascular smooth muscle cells, inducing contraction and elevating systemic arterial blood pressure. This occurs via G protein-coupled receptor signaling, though the specific receptor subtypes activated by (5-7) may differ from canonical AT1R and AT2R used by Angiotensin II. The peptide also exhibits dipsogenic activity, stimulating thirst centers in the brain. In vitro, Angiotensin 1/2 (5-7) and other N-terminally truncated angiotensin peptides significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor on host cells, a property not observed with the full-length Angiotensin I (Oliveira et al., 2025). This effect may have implications for viral entry and pathogenesis, especially in tissues with low ACE2 expression.

Evidence & Benchmarks

• Angiotensin 1/2 (5-7) is derived from angiotensinogen by sequential proteolytic processing in the renin-angiotensin system (Oliveira et al., 2025).
• The peptide sequence H2N-Ile-His-Pro-OH has a confirmed molecular weight of 365.43 Da and a purity of 98.36% (HPLC) (APExBIO).
• Solubility benchmarks: ≥36.5 mg/mL in DMSO, ≥50 mg/mL in ethanol, and ≥50 mg/mL in water at room temperature (APExBIO).
• Angiotensin (5-7) and similar N-terminally truncated peptides increase SARS-CoV-2 spike–AXL receptor binding by up to 2.7-fold in antibody-based assays (Oliveira et al., 2025).
• Canonical vasoconstrictor and dipsogenic effects documented in in vivo and in vitro models (Angiotensin 1/2 (5-7): Vasoconstrictor Peptide in Renin-A...).
• Stable as a solid at -20°C; long-term solution storage is not recommended for optimal stability (APExBIO).

Applications, Limits & Misconceptions

Angiotensin 1/2 (5-7) is widely used in hypertension research, renin-angiotensin system signaling studies, and modeling of SARS-CoV-2 spike protein interactions. Its robust solubility and purity enable precise dosing and reproducible results in cellular, tissue, and animal models. The peptide is suitable for mechanistic studies of blood pressure regulation, vascular reactivity, and dipsogenic pathways. Translational research also leverages Angiotensin 1/2 (5-7) to probe viral pathogenesis, especially in the context of alternative SARS-CoV-2 entry mechanisms (Oliveira et al., 2025).

Compared to "Angiotensin 1/2 (5-7): A Vasoconstrictor Peptide for Adva...", this article provides an updated synthesis of recent viral pathogenesis findings and links molecular properties to translational relevance.

See also "Angiotensin 1/2 (5-7): Mechanistic Insights for Hypertens..." for a complementary perspective on hypertension models; this article adds new benchmarks and clarification on peptide storage and solubility conditions.

Common Pitfalls or Misconceptions

• Not a pan-ACE2 modulator: Angiotensin 1/2 (5-7) enhances spike–AXL binding, not direct ACE2–spike interactions (Oliveira et al., 2025).
• Storage sensitivity: Extended storage in solution may reduce activity; prepare fresh aliquots before each experiment (APExBIO).
• Species differences: While conserved, receptor profiles and downstream effects may vary between species; verify in specific models.
• Not suitable for chronic in vivo dosing studies: Short half-life and rapid clearance limit chronic systemic applications.
• No direct antagonism of angiotensin receptors: The peptide acts as an agonist, not an antagonist, in canonical RAS pathways.

Workflow Integration & Parameters

Angiotensin 1/2 (5-7) (SKU: A1049) is supplied by APExBIO as a solid, with shipping under blue ice conditions for small molecules. Reconstitution is recommended at ≥36.5 mg/mL in DMSO, or ≥50 mg/mL in ethanol or water, at room temperature. For best results, use freshly prepared solutions and avoid repeated freeze-thaw cycles. Peptide purity is validated by HPLC (98.36%) and identity by mass spectrometry. Storage at -20°C maintains stability in solid form for up to 24 months. The peptide is compatible with a range of in vitro and in vivo protocols, including vascular reactivity assays, blood pressure telemetry, and viral binding studies. Quality control documentation is available on the product page. For batch-specific data and custom formulations, contact APExBIO technical support.

Conclusion & Outlook

Angiotensin 1/2 (5-7) is a versatile vasoconstrictor peptide hormone supporting advanced research in blood pressure regulation, renin-angiotensin system signaling, and viral pathogenesis. Its validated purity, robust solubility, and mechanistic relevance establish it as a benchmark tool for translational studies. Ongoing research continues to clarify its receptor specificity and role in alternative viral entry pathways. For detailed protocols, refer to the A1049 kit and recent peer-reviewed literature.